---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294822048.md"
description: "In Tuesday's pre-market session, several healthcare stocks showed significant movement. Gainers included Ensysce Biosciences (+55.4%), Adagio Medical (+30.73%), and Galectin Therapeutics (+20.46%). Conversely, losers featured AdaptHealth (-28.4%), Certara (-20.18%), and Prenetics Global (-13.4%). Many of these price shifts coincided with the release of Q2 earnings reports."
datetime: "2026-08-04T12:05:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294822048.md)
  - [en](https://longbridge.com/en/news/294822048.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294822048.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Ensysce Biosciences** (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million.
-   **Adagio Medical Holdings** (NASDAQ:ADGM) stock moved upwards by 30.73% to $0.6. The market value of their outstanding shares is at $10.2 million.
-   **Galectin Therapeutics** (NASDAQ:GALT) stock moved upwards by 20.46% to $3.65. The company's market cap stands at $199.5 million.
-   **Inspire Medical Systems** (NYSE:INSP) stock moved upwards by 14.61% to $59.85. The company's market cap stands at $1.5 billion. The company's, Q2 earnings came out yesterday.
-   **Addex Therapeutics** (NASDAQ:ADXN) stock increased by 12.49% to $5.85.
-   **Exagen** (NASDAQ:XGN) shares rose 12.17% to $5.25. The company's market cap stands at $113.0 million. The company's, Q2 earnings came out today.

### Losers

-   **AdaptHealth** (NASDAQ:AHCO) shares decreased by 28.4% to $7.76 during Tuesday's pre-market session. The company's market cap stands at $1.4 billion. The company's, Q2 earnings came out today.
-   **Certara** (NASDAQ:CERT) stock declined by 20.18% to $6.53. The company's market cap stands at $1.2 billion. The company's, Q2 earnings came out today.
-   **Prenetics Global** (NASDAQ:PRE) shares decreased by 13.4% to $16.04. The market value of their outstanding shares is at $311.6 million.
-   **Pediatrix Medical Group** (NYSE:MD) shares decreased by 12.39% to $23.0. The market value of their outstanding shares is at $2.1 billion. As per the press release, Q2 earnings came out today.
-   **ClearPoint Neuro** (NASDAQ:CLPT) stock decreased by 12.29% to $13.49. The company's market cap stands at $461.2 million. As per the news, the Q2 earnings report came out yesterday.
-   **Bruker** (NASDAQ:BRKR) shares decreased by 12.15% to $56.5. The company's market cap stands at $9.7 billion. As per the press release, Q2 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [GALT.US](https://longbridge.com/en/quote/GALT.US.md)
- [ENSC.US](https://longbridge.com/en/quote/ENSC.US.md)
- [CERT.US](https://longbridge.com/en/quote/CERT.US.md)
- [AHCO.US](https://longbridge.com/en/quote/AHCO.US.md)
- [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md)
- [PRE.US](https://longbridge.com/en/quote/PRE.US.md)
- [INSP.US](https://longbridge.com/en/quote/INSP.US.md)
- [ADXN.US](https://longbridge.com/en/quote/ADXN.US.md)
- [XGN.US](https://longbridge.com/en/quote/XGN.US.md)
- [MD.US](https://longbridge.com/en/quote/MD.US.md)
- [CLPT.US](https://longbridge.com/en/quote/CLPT.US.md)
- [BRKR.US](https://longbridge.com/en/quote/BRKR.US.md)
- [ENSCW.US](https://longbridge.com/en/quote/ENSCW.US.md)
- [PRENW.US](https://longbridge.com/en/quote/PRENW.US.md)
- [BRKRP.US](https://longbridge.com/en/quote/BRKRP.US.md)

## Related News & Research

- [Ensysce Biosciences raises over $21 million in Series C preferred stock private placement](https://longbridge.com/en/news/296829867.md)
- [Prenetics’ IM8 Brings Lily Collins On Board as Global Ambassador and Shareholder Amid Raised 2026–2027 Guidance](https://longbridge.com/en/news/296510440.md)
- [Prenetics Global Q2 revenue jumps on AI brand growth](https://longbridge.com/en/news/296222403.md)
- [Prenetics Global (NASDAQ:PRE) Posts Earnings Results, Beats Expectations By $0.32 EPS](https://longbridge.com/en/news/296224368.md)
- [Ensysce Biosciences director Bob G. Gower acquires common shares worth $443,025.17](https://longbridge.com/en/news/296210667.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**